Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Bullboard Posts
Comment by CravenRaven101on Dec 05, 2011 9:32am
244 Views
Post# 19291529

RE: Feeling Sorry Part 3, Questions

RE: Feeling Sorry Part 3, QuestionsMy price for ONC is far less modest than $10.00... MY target is based on the P_O_T_E_N_T_I_A_L of Reo, OF course IF someone comes in with an offer prior to ONC's ability to monetize all their hard work I would consder myself "scr*w*d... and WOULD consider anything less than $25.00/share a lowball... Cancer is not soon going away...sadly oncology IS a growth industry for Pharma Companies... should we as the riders opon the white frock coat tails of Mr. Thompson profit? Why not?

and for disclosure... I DO not now, NOR have I ever been an employee of a bank, equity trader, or ANY financial institution who's business it is, in whole or in part, to trade shares, bonds or ANY financial instruments... I deal with hard assets.

In any case it appears you need a change in meds again Germini, OR perhaps a more diligent care giver.

as always it is MY opinion git yer own.
Bullboard Posts